Prior to founding Veirulence, Rory worked as a Strategy Consultant at Blue Matter, a life science consulting firm. Working with major global pharmaceutical companies and biotechs, he gained valuable experience in clinical and commercial drug development.

Rory attended the University of Leeds as a Biological Sciences Scholar, where he achieved 1st Class (Hons) in Medical Sciences. He completed his PhD at the University of Cambridge as a Hughes Hall Scholar and a David James Pharmacology Scholar. His thesis investigated virulence targeting small molecules against P. aeruginosa and is the basis on which Veirulence was founded.